The prognostic value of the D-dimer test in cancer patients treated with and without low-molecular-weight heparin.
M
M
Di Nisio
C P W
CP
Klerk
J C M
JC
Meijers
H R
HR
Büller
D000925:Anticoagulants / Q000627:therapeutic use*; D001780:Blood Coagulation Tests; D005338:Fibrin Fibrinogen Degradation Products / Q000096:biosynthesis*; D006801:Humans; D017762:Nadroparin / Q000627:therapeutic use*; D009369:Neoplasms / Q000097:blood* / Q000175:diagnosis / Q000401:mortality; D010919:Placebos; D011379:Prognosis; D012189:Retrospective Studies; D013997:Time Factors; D016896:Treatment Outcome
D000925:Anticoagulants; D005338:Fibrin Fibrinogen Degradation Products; D017762:Nadroparin; D010919:Placebos; C036309:fibrin fragment D